Fig. 5From: CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancersRelation of CEP55 expression with tumor distant metastasis (panel A), tumor mutational burden (panel B), microsatellite instability (panel C), and neoantigen (panel D) of cancer patients. nsp > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001Back to article page